Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study
Public ClinicalTrials.gov record NCT02669433. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Double-Blind, Randomized, Placebo-Controlled Study of RVT-101 in Subjects With Dementia With Lewy Bodies (DLB)
Study identification
- NCT ID
- NCT02669433
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Axovant Sciences Ltd.
- Industry
- Enrollment
- 484 participants
Conditions and interventions
Conditions
Interventions
- RVT-101 35 mg Drug
- RVT-101 70 mg Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2015
- Primary completion
- Nov 30, 2017
- Completion
- Nov 30, 2017
- Last update posted
- Apr 25, 2019
2016 – 2017
United States locations
- U.S. sites
- 31
- U.S. states
- 18
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| US138 | Phoenix | Arizona | 85006 | — |
| US108 | Phoenix | Arizona | 85013 | — |
| US139 | Sun City | Arizona | 85351 | — |
| US125 | Tucson | Arizona | 85704 | — |
| US119 | Irvine | California | 92868 | — |
| US134 | Oxnard | California | 93030 | — |
| US133 | Rancho Mirage | California | 92270 | — |
| US140 | Sacramento | California | 95816 | — |
| US141 | Englewood | Colorado | 80113 | — |
| US123 | Washington D.C. | District of Columbia | 20007 | — |
| US104 | Boca Raton | Florida | 33431 | — |
| US116 | Boca Raton | Florida | 33486 | — |
| US111 | Jacksonville | Florida | 32224 | — |
| US122 | Orlando | Florida | 32806 | — |
| US137 | Palm Beach Gardens | Florida | 33410 | — |
| US126 | Tampa | Florida | 33609 | — |
| US136 | Atlanta | Georgia | 30331 | — |
| US112 | Chicago | Illinois | 60612 | — |
| US118 | Indianapolis | Indiana | 46202 | — |
| US105 | Lexington | Kentucky | 40536 | — |
| US135 | Newton | Massachusetts | 02459 | — |
| US130 | Quincy | Massachusetts | 02196 | — |
| US102 | Rochester | Minnesota | 55905 | — |
| US109 | New York | New York | 10032 | — |
| US100 | Chapel Hill | North Carolina | 27514 | — |
| US110 | Cleveland | Ohio | 44195 | — |
| US106 | Columbus | Ohio | 43210 | — |
| US131 | Portland | Oregon | 97210 | — |
| US120 | Willow Grove | Pennsylvania | 19090 | — |
| US124 | Dallas | Texas | 75390 | — |
| US101 | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02669433, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 25, 2019 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02669433 live on ClinicalTrials.gov.